{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:11:36Z","timestamp":1762899096370},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,1,11]],"date-time":"2015-01-11T00:00:00Z","timestamp":1420934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00345-015-1481-z","type":"journal-article","created":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T05:26:09Z","timestamp":1420867569000},"page":"1511-1518","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with 18F-fluorocholine positron emission tomography\/computed tomography"],"prefix":"10.1007","volume":"33","author":[{"given":"Giuseppe","family":"Simone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Battista","family":"Di Pierro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Papalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Sciuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Rea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariaconsiglia","family":"Ferriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Guaglianone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Ludovico","family":"Maini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Gallucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,11]]},"reference":[{"key":"1481_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","volume":"59","author":"A Heidenreich","year":"2010","unstructured":"Heidenreich A, Bellmunt J, Bolla M et al (2010) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61\u201371","journal-title":"Eur Urol"},{"key":"1481_CR2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.juro.2010.10.057","volume":"185","author":"SE Eggener","year":"2011","unstructured":"Eggener SE, Scardino PT, Walsh PC et al (2011) Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 185:869\u2013875","journal-title":"J Urol"},{"key":"1481_CR3","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.juro.2012.08.028","volume":"188","author":"JK Mullins","year":"2012","unstructured":"Mullins JK, Feng Z, Trock BJ et al (2012) The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary. J Urol 188:2219\u20132224","journal-title":"J Urol"},{"key":"1481_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0090-4295(93)90159-8","volume":"41","author":"WR Morgan","year":"1993","unstructured":"Morgan WR, Bergstralh EJ, Zincke H (1993) Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer. Urology 41:113\u2013120","journal-title":"Urology"},{"key":"1481_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.pcan.4500732","volume":"7","author":"SR Bott","year":"2004","unstructured":"Bott SR (2004) Management of recurrent disease after radical prostatectomy. Prostate Cancer Prostatic Dis 7:211\u2013216","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1481_CR6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eururo.2011.01.025","volume":"59","author":"N Mottet","year":"2011","unstructured":"Mottet N, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59:572\u2013583","journal-title":"Eur Urol"},{"key":"1481_CR7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1464-410X.2003.04692.x","volume":"93","author":"V Scattoni","year":"2004","unstructured":"Scattoni V, Montorsi F, Picchio M et al (2004) Diagnosis of local recurrence after radical prostatectomy. BJU Int 93:680\u2013688","journal-title":"BJU Int"},{"key":"1481_CR8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0302-2838(03)00320-8","volume":"44","author":"V Scattoni","year":"2003","unstructured":"Scattoni V, Roscigno M, Raber M et al (2003) Multiple vesicourethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage. Eur Urol 44:407\u2013414","journal-title":"Eur Urol"},{"key":"1481_CR9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eururo.2010.09.004","volume":"59","author":"M Picchio","year":"2011","unstructured":"Picchio M, Briganti A, Fanti S et al (2011) The role of choline positron emission tomography\/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol 59:51\u201360","journal-title":"Eur Urol"},{"key":"1481_CR10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0022-5347(17)41037-8","volume":"141","author":"PH Lange","year":"1989","unstructured":"Lange PH, Ercole CJ, Lightner DJ et al (1989) The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 141:873\u2013879","journal-title":"J Urol"},{"key":"1481_CR11","first-page":"245","volume":"53","author":"M Picchio","year":"2009","unstructured":"Picchio M, Crivellaro C, Giovacchini G, Gianolli L, Messa C (2009) PET-CT for treatment planning in prostate cancer. Q J Nucl Med Mol Imaging 53:245\u2013268","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1481_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MOU.0b013e3282f13ac3","volume":"18","author":"D Pucar","year":"2008","unstructured":"Pucar D, Sella T, Schoder H (2008) The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. Curr Opin Urol 18:87\u201397","journal-title":"Curr Opin Urol"},{"key":"1481_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000144059","volume":"81","author":"L Rinnab","year":"2008","unstructured":"Rinnab L, Mottaghy FM, Simon J et al (2008) [11C]Choline PET\/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study. Urol Int 81:191\u2013197","journal-title":"Urol Int"},{"key":"1481_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00259-007-0581-4","volume":"35","author":"BJ Krause","year":"2008","unstructured":"Krause BJ, Souvatzoglou M, Tuncel M et al (2008) The detection rate of [11C]Choline-PET\/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 35:18\u201323","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1481_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00259-007-0552-9","volume":"35","author":"DB Husarik","year":"2008","unstructured":"Husarik DB, Miralbell R, Dubs M et al (2008) Evaluation of [(18)F]-choline PET\/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 35:253\u2013263","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1481_CR16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11547-008-0263-8","volume":"113","author":"E Pelosi","year":"2008","unstructured":"Pelosi E, Arena V, Skanjeti A et al (2008) Role of whole-body 18F-choline PET\/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer. Radiol Med 113:895\u2013904","journal-title":"Radiol Med"},{"key":"1481_CR17","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.108.061507","volume":"50","author":"P Castellucci","year":"2009","unstructured":"Castellucci P, Fuccio C, Nanni C et al (2009) Influence of trigger PSA and PSA kinetics on 11C-Choline PET\/CT detection rate in patients with biochemical relapse after radical prostatectomy. J Nucl Med 50:1394\u20131400","journal-title":"J Nucl Med"},{"key":"1481_CR18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ejrad.2011.01.095","volume":"81","author":"V Panebianco","year":"2012","unstructured":"Panebianco V, Sciarra A, Lisi D et al (2012) Prostate cancer: 1HMRS-DCEMR at 3 T versus [(18)F]choline PET\/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J Radiol 81:700\u2013708","journal-title":"Eur J Radiol"},{"key":"1481_CR19","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1464-410X.2007.06772.x","volume":"99","author":"H Vees","year":"2007","unstructured":"Vees H, Buchegger F, Albrecht S et al (2007) 18F-choline and\/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1\u00a0ng\/mL) after radical prostatectomy. BJU Int 99:1415\u20131420","journal-title":"BJU Int"},{"key":"1481_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.juro.2012.09.001","volume":"189","author":"G Giovacchini","year":"2013","unstructured":"Giovacchini G, Picchio M, Garcia-Parra R et al (2013) [11C]Choline positron emission tomography\/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen. J Urol 189:105\u2013110","journal-title":"J Urol"},{"key":"1481_CR21","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","volume":"25","author":"AJ Stephenson","year":"2007","unstructured":"Stephenson AJ, Scardino PT, Kattan MW et al (2007) Predicting outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25:2035\u20132041","journal-title":"J Clin Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-015-1481-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-015-1481-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-015-1481-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T14:12:59Z","timestamp":1566223979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-015-1481-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,11]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1481"],"URL":"https:\/\/doi.org\/10.1007\/s00345-015-1481-z","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,11]]}}}